Literature DB >> 17457909

Prevalence of the most common high-risk HPV genotypes among women in three new independent states of the former Soviet Union.

Satu-Maria A Kulmala1, Irena P Shabalova, Nikolay Petrovitchev, Kari J Syrjänen, Ulf B Gyllensten, Stina M Syrjänen.   

Abstract

Type distribution of HPV has been studied in different geographic regions, but the data are scanty from the new independent states of the former Soviet Union. Here the HPV prevalence and distribution of the most frequent high-risk HPV types among 3,187 women at different risk for HPV and cervical intraepithelial neoplasia in Russia, Belarus, and Latvia is reported. HPV detection, type distribution and viral load analysis in DNA samples from cervical scrapes were done with real-time PCR-based assay detecting HPV types 16, 18, 31, 33, 35, 39, 45, 52, and 58. The overall HPV prevalence was 31.2%, HPV16 was the most prevalent type followed by HPV31 and HPV33 group. The overall HPV prevalences in Russia, Belarus and Latvia were 33.4%, 27.5%, and 26.2%. The type distributions were similar in these countries, except for Latvia where HPV39 was the third prevalent genotype. HPV prevalence was highest (40.8%) among women from sexually transmitted disease clinic, followed by 30.9% among gynecological outpatients and 27.2% in screening patients. HPV detection increased with cytological abnormality (P = 0.0001) and lesion grade in the biopsy (P = 0.0001), from 27% to 72% in normal samples to cancer, and from 64% to 77% in cervical intraepithelial neoplasia 1 to cancer. The normalized viral loads varied greatly between and among different HPV-types. The mean log HPV33 group copies/cell increased from negative for intraepithelial lesions to cancer (P = 0.049). Distribution of the most common high-risk HPV-types seems to be similar in these countries as reported in other major geographical regions. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17457909     DOI: 10.1002/jmv.20839

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  10 in total

1.  The prevalence of human papillomavirus in oral premalignant lesions and squamous cell carcinoma in comparison to cervical lesions used as a positive control.

Authors:  Miki Ishibashi; Mitsunobu Kishino; Sunao Sato; Eiichi Morii; Yuzo Ogawa; Katsuyuki Aozasa; Mikihiko Kogo; Satoru Toyosawa
Journal:  Int J Clin Oncol       Date:  2011-04-29       Impact factor: 3.402

2.  Estimating the Burden of Illness Related to Genital Warts in Russia: A Cross-Sectional Study.

Authors:  Vera N Prilepskaya; Mikhail Gomberg; Smita Kothari; Karen Yee; Amit Kulkarni; Suzanne M Garland; Anna R Giuliano
Journal:  J Health Econ Outcomes Res       Date:  2020-10-07

3.  Human Papillomavirus (HPV) Type Distribution in Females with Abnormal Cervical Cytology. A Correlation with Histological Study.

Authors:  Fernando Cobo; Angel Concha; Marta Ortiz
Journal:  Open Virol J       Date:  2009-09-04

4.  Population-based type-specific prevalence of high-risk human papillomavirus infection in Estonia.

Authors:  Anneli Uusküla; Mart Kals; Liina Kosenkranius; Louise-Anne McNutt; Jack DeHovitz J
Journal:  BMC Infect Dis       Date:  2010-03-11       Impact factor: 3.090

5.  Development and evaluation of a PCR and mass spectroscopy (PCR-MS)-based method for quantitative, type-specific detection of human papillomavirus.

Authors:  Divya A Patel; Yang-Jen Shih; Duane W Newton; Claire W Michael; Paul A Oeth; Michael D Kane; Anthony W Opipari; Mack T Ruffin; Linda M Kalikin; David M Kurnit
Journal:  J Virol Methods       Date:  2009-05-03       Impact factor: 2.014

6.  Human papillomavirus genotype distribution in Czech women and men with diseases etiologically linked to HPV.

Authors:  Ruth Tachezy; Jana Smahelova; Martina Salakova; Marc Arbyn; Lukas Rob; Petr Skapa; Tomas Jirasek; Eva Hamsikova
Journal:  PLoS One       Date:  2011-07-13       Impact factor: 3.240

7.  Human Papillomavirus Infection and Cervical Neoplasia among Migrant Women Living in Italy.

Authors:  Maria Lina Tornesello; Paolo Giorgi Rossi; Luigi Buonaguro; Franco Maria Buonaguro
Journal:  Front Oncol       Date:  2014-02-20       Impact factor: 6.244

8.  Chronic disease mortality associated with infectious agents: a comparative cohort study of migrants from the Former Soviet Union in Israel and Germany.

Authors:  Jördis J Ott; Ari M Paltiel; Volker Winkler; Heiko Becher
Journal:  BMC Public Health       Date:  2008-04-09       Impact factor: 3.295

9.  The prevalence of human papillomavirus and its impact on cervical dysplasia in Northern Canada.

Authors:  Ying Jiang; Paul Brassard; Alberto Severini; Yang Mao; Y Anita Li; Julie Laroche; Susan Chatwood; Andre Corriveau; Kami Kandola; Brendan Hanley; Isaac Sobol; Muna Ar-Rushdi; Gordon Johnson; Jane Lo; Sam Ratnam; Tom Wong; Alain Demers; Gayatri Jayaraman; Stephanie Totten; Howard Morrison
Journal:  Infect Agent Cancer       Date:  2013-07-01       Impact factor: 2.965

10.  Human papillomavirus type-specific prevalence in the cervical cancer screening population of Czech women.

Authors:  Ruth Tachezy; Jana Smahelova; Jana Kaspirkova; Martina Salakova
Journal:  PLoS One       Date:  2013-11-12       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.